| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$65 |
Neurizon to present Q1 FY2026 Results
|
31 Oct 2025 9:35AM |
$0.110 |
$0.095 |
fallen by
13.64%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful entry into HEALEY ALS Platform Trial after FDA lifted the clinical hold for NUZ-001.
- Completed a $5.2 million share placement with strong investor demand.
- Secured $1.5 million loan against the R&D Tax Incentive rebate.
- Alignment of U.S. FDA approval with global market access strategy.
- Active engagement in global industry conferences and ALS community initiatives.
- Ongoing development and expansion efforts for NUZ-001 and other neurodegenerative applications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Codeifai Limited (CDE) ORDINARY FULLY PAID |
Industrials |
$11 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:34AM |
$0.013 |
$0.011 |
fallen by
15.38%
|
|
CDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities of $566,000.
- Cash receipts from customers totaled $165,000.
- Significant expenses in research and development, staff, and corporate costs.
- Raised $2.53 million from equity issuance in August 2025.
- Loan facility agreement with Harbour Capital Opportunities Fund Pty Limited.
- Convertible loan with J F Houston Holdings Pty Limited.
- Held $1.524 million in cash and cash equivalents at quarter-end.
- Integration of GS1 Digital Link into ConnectQR platform.
- Termination of Trust Codes Global acquisition.
- Focus on QuantumAI Secure technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hawk Resources Limited (HWK) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:34AM |
$0.034 |
$0.040 |
risen by
17.65%
|
|
HWK - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities for the quarter was $210,000.
- Net cash used in investing activities amounted to $355,000.
- No cash flow from financing activities was recorded in the quarter.
- Total cash and cash equivalents at the end of the period were $392,000.
- Payments to related parties during the quarter totaled $62,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Middle Island Resources Limited (MDI) ORDINARY FULLY PAID |
Materials |
$61 |
Board Change to Drive Accelerated Serbian Strategy
|
31 Oct 2025 9:34AM |
$0.035 |
$0.061 |
risen by
74.29%
|
|
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$36 |
Investor Presentation
|
31 Oct 2025 9:34AM |
$0.100 |
$0.075 |
fallen by
25%
|
|
| Apollo Minerals Limited (AON) ORDINARY FULLY PAID |
Materials |
$62 |
September 2025 Quarterly Report
|
31 Oct 2025 9:33AM |
$0.011 |
$0.054 |
risen by
390.91%
|
|
AON - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Phase 2 drilling at Salanie Gold Project reveals potential gold mineralization.
- Exploration continued at Kroussou Zinc-Lead Project with field mapping and sampling.
- Apollo reported a net cash outflow from operating activities.
- The company holds cash reserves and equity investments in Constellation Resources and Bindi Metals.
- Apollo plans to secure additional funding to continue operations and project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Advanced Innergy Holdings Limited (AIH) ORDINARY FULLY PAID |
Industrials |
$396 |
AIH Commences Trading on ASX, Reconfirms Guidance
|
31 Oct 2025 9:33AM |
$1.000 |
$0.938 |
fallen by
6.25%
|
|
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$204 |
Final approval received for Otavi Project acquisition
|
31 Oct 2025 9:33AM |
$0.430 |
$1.000 |
risen by
132.56%
|
|
MM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Midas Minerals Ltd has received final approval for the acquisition of the Otavi Copper Project in Namibia.
- The Namibian Competition Commission granted unconditional merger control clearance.
- The completion of the acquisition is expected in November 2025.
- Midas plans to commence drilling at Otavi in Q4 2025 with four rigs.
- The Otavi Project covers 1,776km2 and includes two notable deposits, T13 and Deblin.
- Midas has also secured an option over the South Otavi Project, commencing drilling in early September 2025.
- Midas remains well-funded with $15.3 million in cash following an $11.5 million placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cooper Metals Limited (CPM) ORDINARY FULLY PAID |
Materials |
$4 |
Quarterly Activities Report and Appendix 5B
|
31 Oct 2025 9:33AM |
$0.062 |
$0.053 |
fallen by
14.52%
|
|
CPM - Price-sensitive ASX Announcement
Full Release
Key Points
- Heritage clearance completed at Ardmore North, Mt Isa East.
- Option agreement executed to divest 80% of Gilberton Project to Sybella Metals.
- Focus on advancing projects in Mt Isa East, QLD, and Gooroo, WA.
- Cash reserves at $1.63 million at quarter end.
- Approximately $113,000 spent on exploration activities.
- Board actively reviewing third-party opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Superior Resources Limited (SPQ) ORDINARY FULLY PAID |
Materials |
$16 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:33AM |
$0.009 |
$0.006 |
fallen by
33.33%
|
|
SPQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Superior Resources Limited expanded Greenvale Project by 56% with new exploration permits.
- High-grade Cu-Au-Ag assay results reported from Hall’s Reward and Telegraph Prospects.
- Steam Engine Gold Project feasibility studies and regulatory processes are ongoing.
- Net cash used in operating activities was A$241,000 with a closing cash balance of A$299,000.
- The company expects to raise additional funds as available funding covers less than one quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PolarX Limited (PXX) ORDINARY FULLY PAID |
Materials |
$52 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:32AM |
$0.023 |
$0.019 |
fallen by
17.39%
|
|
PXX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow from operating activities: $417,000
- Net cash outflow from investing activities: $2,907,000
- Net cash inflow from financing activities: $4,815,000
- Cash and cash equivalents at end of period: $4,349,000
- Significant investments in exploration and evaluation
- Alaska Range Project offers significant NPV and IRR
- Expansion in Humboldt Range Project with new claims
- Upcoming drilling campaign in Humboldt Range Project
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AustChina Holdings Limited (AUH) ORDINARY FULLY PAID |
Energy |
- |
Addendum to Notice of Annual General Meeting
|
31 Oct 2025 9:32AM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$36 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:31AM |
$0.100 |
$0.075 |
fallen by
25%
|
|
AR9 - Price-sensitive ASX Announcement
Full Release
Key Points
- archTIS Limited acquired Spirion LLC, significantly increasing ARR to A$18.9 million.
- The company ended the quarter with A$13.8 million in cash, supporting U.S. expansion.
- Licensing revenue comprised 78% of total revenue, delivering a 75% gross margin.
- The net cash from financing activities was A$26.39 million, leading to a positive cash position.
- The company secured additional U.S. Department of Defense contracts.
- archTIS is focusing on transitioning to a higher-margin business model.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GBM Resources Limited (GBZ) ORDINARY FULLY PAID |
Materials |
$131 |
September 2025 Quarterly Report
|
31 Oct 2025 9:31AM |
$0.039 |
$0.029 |
fallen by
25.64%
|
|
GBZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of Stage 1 drilling at Twin Hills to expand resources.
- Full ownership consolidation of the Mt Coolon Gold Project.
- Reduced operation at White Dam with revenue of $155,000 and expenditures of $340,000.
- Appointment of Daniel Hastings as Chief Executive Officer.
- Successful $40 million fundraising through share placements.
- Focus on unlocking value from non-core asset portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fin Resources Limited (FIN) |
Materials |
$14 |
Quarterly Activities Report & Appendix 5B
|
31 Oct 2025 9:30AM |
$0.009 |
$0.013 |
risen by
44.44%
|
|
FIN - Price-sensitive ASX Announcement
Full Release
Key Points
- No changes during the September 2025 quarter for the Cancet West project.
- Cancet West project remains active with expiry dates extending into 2026.
- Appendix 5B includes a detailed cash flow report for the mining exploration entity.
- Report summarizes the status of active projects and provides insights into financial activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ansell Limited (ANN) ORDINARY FULLY PAID |
Health Care |
$4,859 |
Update - Notification of buy-back - ANN
|
31 Oct 2025 9:30AM |
$36.070 |
$33.290 |
fallen by
7.71%
|
|
| Australian Bond Exchange Holdings Limited (ABE) ORDINARY FULLY PAID |
Financials |
$4 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:30AM |
$0.027 |
$0.032 |
risen by
18.52%
|
|
ABE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net operating cash outflow of $0.7 million for the quarter.
- Expectations of reduced cash usage in future quarters.
- Plans to raise funds through share and convertible note issuance.
- Development of Credit Analysis AI Tool and payment infrastructure enhancements.
- Successful variation of AFSL for cost savings and revenue opportunities.
- Payments of $191,465 to related parties for director remuneration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SRJ Technologies Group plc (SRJ) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$17 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:30AM |
$0.014 |
$0.012 |
fallen by
14.29%
|
|
SRJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed strategic acquisition of a UAE National Oil Company-registered entity.
- Secured a joint venture agreement with CAPSA Engineering & Contracting LLC.
- Raised £1.4 million through a placement and entitlement offer.
- Advanced cost-out and restructuring program, achieving significant savings.
- Commercial momentum with Air Control Entech, including new contracts.
- Ongoing development and adoption of BoltEx® technology.
- Positioning for scalable growth in FY26 with focus on Middle East market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Action Limited (EAX) ORDINARY FULLY PAID |
Industrials |
$19 |
Notification of cessation of securities - EAX
|
31 Oct 2025 9:30AM |
$0.480 |
$0.480 |
fallen by
0%
|
|
| Turaco Gold Limited (TCG) ORDINARY FULLY PAID |
Materials |
$721 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:30AM |
$0.455 |
$0.685 |
risen by
50.55%
|
|
TCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Turaco Gold is active in mining exploration in Côte d'Ivoire's Afema Project.
- Significant gold discoveries at Adiopan and Asupiri deposits.
- Updated Mineral Resource Estimate totals 4.06 million ounces of gold.
- Key financial activities include operating, investing, and financing cash flows.
- $1.077 million paid to Endeavour Mining for Afema Project acquisition.
- Focus on enhancing resource estimates and advancing project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$747 |
Update - Notification of buy-back - RF1
|
31 Oct 2025 9:30AM |
$3.260 |
$3.550 |
risen by
8.90%
|
|
| Wide Open Agriculture Ltd (WOA) ORDINARY FULLY PAID |
Consumer Staple |
$11 |
Quarterly Activities Report and Appendix 4C
|
31 Oct 2025 9:30AM |
$0.022 |
$0.018 |
fallen by
20.45%
|
|
WOA - Price-sensitive ASX Announcement
Full Release
Key Points
- Univar Solutions China launched WOA's lupin protein in the beverage and nutrition sectors.
- Lupin Sustainability Study confirmed lupin's low carbon footprint.
- Focus on cost reduction and cash preservation with moderated production.
- Initiated Pre-Feasibility Study for a Western Australian manufacturing facility.
- Appointed Claudia Kwan as Non-Executive Director to strengthen governance.
- Quarter ended with $2 million in cash and lower expected burn rate.
- WOA's mission to reshape the future of food with lupin protein.
- WOA joined the Australian delegation for the 2025 China International Import Expo.
- Strategic partnerships are crucial for efficient scale-up and sustained growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$87 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 9:30AM |
$0.011 |
$0.008 |
fallen by
27.27%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- Alterity Therapeutics Limited reported a net cash outflow from operating activities of A$5.34 million for the quarter.
- The company raised A$20 million in gross proceeds from a strategic placement to advance its programs.
- As of 30 September 2025, Alterity had cash and cash equivalents totaling A$54.563 million.
- Alterity did not have any cash flows from investing activities during the quarter.
- The estimated quarters of funding available is 10.2 based on current cash flows.
- The primary use of funds was for research and development, staff costs, and administration.
- Proceeds from financing activities primarily came from the issue of equity securities.
- No dividends were paid or proposed by the company during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AustChina Holdings Limited (AUH) ORDINARY FULLY PAID |
Energy |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:29AM |
$0.002 |
$0.002 |
risen by
33.33%
|
|
AUH - Price-sensitive ASX Announcement
Full Release
Key Points
- AustChina Holdings Limited's quarterly report for the period ending 30 September 2025.
- Net cash used in operating activities totaled $195,000 for the quarter.
- Cash and cash equivalents decreased from $280,000 to $46,000 during the quarter.
- A short-term loan agreement for $100,000 was entered with a director-related entity.
- A non-binding Letter of Intent for a $1.5 million equity placement was received.
- Payments to directors and their associates amounted to $31,000.
- Estimated quarters of funding available is 0.2, indicating financial constraints.
- Directors believe sufficient cash is available to meet business objectives.
- Planning for new project acquisitions is in place to enhance the project portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$4 |
Activities Report September 2025 and Appendix 4C
|
31 Oct 2025 9:29AM |
$0.010 |
$0.008 |
fallen by
20%
|
|
OSX - Price-sensitive ASX Announcement
Full Release
Key Points
- Osteopore recorded a revenue of AUD 812K for Q3 CY25, marking a 7% year-on-year growth.
- The company secured market approval in Switzerland under the EU MDR clearance for its orthopedic and cranial implants.
- Osteopore's partnership with Zimmer Biomet led to a threefold increase in implant sales in Europe, the Middle East, Africa, and Asia Pacific.
- Osteopore won tender bids for two major public hospitals in Vietnam for orthopedic products.
- The company reported net cash used in operating activities of approximately A$664,000 for the quarter.
- Osteopore maintains access to a redeemable convertible note facility with a nominal value of up to A$20,000,000, with A$4,000,000 drawn as of September 2025.
- Payments to related parties during the quarter amounted to approximately A$199,000.
- Osteopore has a cash balance of approximately A$1,081,000 at the end of the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
